Key statistics
As of last trade Quince Therapeutics Inc (QNCX:NSQ) traded at 1.83, -14.51% below its 52-week high of 2.14, set on Nov 15, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.85 |
---|---|
High | 1.85 |
Low | 1.80 |
Bid | 1.80 |
Offer | 1.83 |
Previous close | 1.84 |
Average volume | 377.37k |
---|---|
Shares outstanding | 43.28m |
Free float | 37.33m |
P/E (TTM) | -- |
Market cap | 79.63m USD |
EPS (TTM) | -1.25 USD |
Data delayed at least 15 minutes, as of Nov 21 2024 15:03 GMT.
More ▼
- Quince Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results
- Quince Therapeutics Presents Data from Prior Phase 3 ATTeST Clinical Trial at 2024 International Congress for Ataxia Research
- Quince Therapeutics Presents Safety Data from Prior Phase 3 ATTeST Clinical Trial at 53rd Child Neurology Society Annual Meeting
- Quince Therapeutics to Participate at Upcoming Investor Conferences
- Quince Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference
More ▼